Archived edition · · Return to the current edition
- News & communityFixing Medicare’s Lab Payment System: Why the RESULTS Act Matters
•••
- News & communityProtecting Patient Access to Ostomy and Urological Supplies
•••
- News & communityTo Make Americans Healthier, We Need to Prioritize Sleep
•••
- News & communityNIH research team lays groundwork for new treatment of Niemann-Pick Type C in infants
•••
- News & communityDr. John H. Powers III to serve as director of NIH’s National Institute of Allergy and Infectious Diseases
•••
- News & communityFor the first time, researchers map out the brain’s behavioral gatekeeper
•••
- News & communityA blood-pressure drug may activate health-promoting brown fat
•••
- News & communityLarge NIH-supported study identifies key underlying pathways in endometriosis
•••
- News & communityAn extra year of secondary school lowered dementia diagnoses later in life
•••
- Policy & safety watchReferenceCMS newsroom: payment, coverage and health-system policySource checked Nov 14, 1:00 AM EST · US
•••
- Policy & safety watchReferenceFDA recalls, market withdrawals and safety alertsSource checked Nov 14, 1:00 AM EST · US
•••
- Policy & safety watchAgency Information Collection Activities: Submission for OMB Review; Comment Request; Correction
•••
- Policy & safety watchMedicare Program; Medicare Part B Monthly Actuarial Rates, Premium Rates, and Annual Deductible Beginning January 1, 2027
•••
- Policy & safety watchMedicare Program; CY 2027 Inpatient Hospital Deductible and Hospital and Extended Care Services Coinsurance Amounts
•••
- Policy & safety watchMedicare and Medicaid Programs; Quarterly Listing of Program Issuances-July Through September 2026
•••
- Policy & safety watchMedicare Program; CY 2027 Part A Premiums for the Uninsured Aged and for Certain Disabled Individuals Who Have Exhausted Other Entitlement
•••
- Policy & safety watchMedicare, Medicaid, and Marketplace Programs; Comprehensive Regulations To Uncover Suspicious Healthcare (CRUSH)
•••
- Policy & safety watchFDA Approves First Drug to Treat Neurological Symptoms of Type 3 Gaucher Disease
•••
- Policy & safety watchFDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
•••
- Policy & safety watchFDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer
•••
- Policy & safety watchFDA Grants Accelerated Approval to a New Treatment for Head and Neck Squamous Cell Carcinoma
•••
- Policy & safety watchFDA Provides Clarity to Support Cell and Gene Therapy Development and Quality
•••
- Medical communities & dataReferenceAHA: hospital and health-system newsSource checked Nov 14, 1:00 AM EST · US
•••
- Medical communities & dataReferenceAdvaMed: medical-technology policy and industry resourcesSource checked Nov 14, 1:00 AM EST · US
•••
- Medical communities & dataReferenceNIH: research news and original study referencesSource checked Nov 14, 1:00 AM EST · US
•••
No matching headlines.
Edition published Nov 20, 2026, 9:50 PM EST. 3 of 5 feeds responded at the latest collection. Selection favors recency and source variety. Original reporting at each link.